Xtalks Announces its July 2017 Webinars
/EINPresswire.com/ -- TORONTO, ON--(Marketwired - July 05, 2017) - Upcoming free, educational webinars from Xtalks Life Sciences will feature topics on clinical trials, clinical data, drug development and drug discovery, pharmacovigilance, pharmacology, pharmaceutical manufacturing and logistics, biosimilars and medical device webinars.
Stay on top of current hot topics through free webinars presented by leading experts in pharma and biotech industries et al. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field! Visit www.xtalks.com to check out our upcoming webinars. Or click below to learn more about each webinar:
CLINICAL TRIALS
CLINICAL DATA
- (July 10) Increasing Patient Enrollment and Patient Data Exchange
- (July 25) EDC and eSource: Combined for Better Data and Faster Insights
DRUG DEVELOPMENT & DRUG DISCOVERY
- (July 6) The Importance of Dose Prediction for Early Drug Development
- (July 12) Vascular and Neural Complications in Rodent Models of Obesity and Type 2 Diabetes
PHARMACOVIGILANCE
PHARMACOLOGY
PHARMACEUTICAL MANUFACTURING
PHARMACEUTICAL LOGISTICS
BIOSIMILARS
MEDICAL DEVICE
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit: http://xtalks.com
For information about hosting a webinar visit: http://xtalks.com/sponsorship.ashx
Contact:
Vicki Pannu
Tel: +1 (416) 977-6555 ext 284
Email: vpannu@xtalks.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.